Publications by authors named "Vikas A Gupta"

Claim this Profile
E
Early CD4+ T cell proliferation and chronic T cell engagement impact myeloma outcomes following T cell engager therapy.
Alyssa M Duffy, Anshika Goenka, Maryam I Azeem, Azmain Taz, Sayalee V Potdar, Vikas A Gupta

J Clin Invest· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility and Safety of Outpatient Model for Administration of Bispecific Antibodies: Proceedings from an International Myeloma Society 21st Annual Meeting Oral Abstract.
Sara A Scott, Danielle L Roberts, Vikas A Gupta, Nisha S Joseph, Craig C Hofmeister

Clin Lymphoma Myeloma Leuk· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infection risk in 158 patients with relapsed/refractory multiple myeloma treated with bispecific antibodies: a single-center experience.
Lorenzo Cani, Sara A Scott, Danielle Roberts, Nisha S Joseph, Craig C Hofmeister, Vikas A Gupta

Haematologica· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Another 1q bites the dust.
Vikas A Gupta, Lawrence H Boise

Blood· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune-aging is linked to clinical malignancy, racial ancestry, and vaccine responses in myeloma.
Sayalee V Potdar, Shivani Kapadia, Maryam I Azeem, Roman Radzievski, Kiran Lakhani, Vikas A Gupta

Blood Adv· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BCL2 inhibition for multiple myeloma and AL amyloidosis.
Lorenzo Cani, Vikas A Gupta, Jonathan L Kaufman

Br J Haematol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heme promotes venetoclax resistance in multiple myeloma through MEK-ERK signaling and purine biosynthesis.
Remya Nair, An H Vu, Abigail K Freer, Karanpreet S Bhatia, Dongxue Wang, Vikas A Gupta

Blood· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of response to venetoclax and therapeutic potential of CDK7 inhibition in multiple myeloma.
Rudra P Dutta, Santiago Thibaud, Violetta Leshchenko, Meghana Ram, David T Melnekoff, Vikas A Gupta

Blood Neoplasia· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Statin-induced Mitochondrial Priming Sensitizes Multiple Myeloma Cells to BCL2 and MCL-1 Inhibitors.
Dennis Juarez, Roberta Buono, Shannon M Matulis, Vikas A Gupta, Madeleine Duong

Cancer Res Commun· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prophylactic tocilizumab to prevent cytokine release syndrome (CRS) with teclistamab: A single-center experience.
Sara A Scott, Ellen M Marin, Kathryn T Maples, Nisha S Joseph, Craig C Hofmeister, Vikas A Gupta

Blood Cancer J· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulation of antigen-specific T cell infiltration and spatial architecture in multiple myeloma and premalignancy.
M Hope Robinson, Nancy Y Villa, David L Jaye, Ajay K Nooka, Alyssa Duffy, Vikas A Gupta

J Clin Invest· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-scale functional genomics identify genes preferentially essential for multiple myeloma cells compared to other neoplasias.
Ricardo de Matos Simoes, Ryosuke Shirasaki, Sondra L Downey-Kopyscinski, Geoffrey M Matthews, Benjamin G Barwick, Vikas A Gupta

Nat Cancer· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Î
β adrenergic signaling regulates hematopoietic stem and progenitor cell commitment and therapy sensitivity in multiple myeloma.
Remya Nair, Vimal Subramaniam, Benjamin G Barwick, Vikas A Gupta, Shannon M Matulis

Haematologica· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic implications of mitochondrial stress-induced proteasome inhibitor resistance in multiple myeloma.
Aditi Sharma, Remya Nair, Abhinav Achreja, Anjali Mittal, Pulkit Gupta, Vikas A Gupta

Sci Adv· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venetoclax ex vivo functional profiling predicts improved progression-free survival.
Vikas A Gupta, Shannon M Matulis, Benjamin G Barwick, R Devin Bog, Conrad W Shebelut

Blood Cancer J· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
It takes T to tango: immunotherapy in MM.
Vikas A Gupta, Madhav V Dhodapkar

Blood· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benefits of Autologous Stem Cell Transplantation for Elderly Myeloma Patients in the Last Quarter of Life.
Nisha S Joseph, Vikas A Gupta, Sarah Wyman, Michael Graiser, Jonathan L Kaufman

Transplant Cell Ther· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PI3Kδ/γ inhibition promotes human CART cell epigenetic and metabolic reprogramming to enhance antitumor cytotoxicity.
Christopher Ronald Funk, Shuhua Wang, Kevin Z Chen, Alexandra Waller, Aditi Sharma, Vikas A Gupta

Blood· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aberrant Extrafollicular B Cells, Immune Dysfunction, Myeloid Inflammation, and MyD88-Mutant Progenitors Precede Waldenstrom Macroglobulinemia.
Akhilesh Kaushal, Ajay K Nooka, Allison R Carr, Katherine E Pendleton, Benjamin G Barwick, Vikas A Gupta

Blood Cancer Discov· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venetoclax sensitivity in multiple myeloma is associated with B-cell gene expression.
Vikas A Gupta, Benjamin G Barwick, Shannon M Matulis, Ryosuke Shirasaki, David L Jaye

Blood· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chromatin Accessibility Identifies Regulatory Elements Predictive of Gene Expression and Disease Outcome in Multiple Myeloma.
Benjamin G Barwick, Vikas A Gupta, Shannon M Matulis, Jonathan C Patton, Doris R Powell

Clin Cancer Res· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BCL2 Family Inhibitors in the Biology and Treatment of Multiple Myeloma.
Vikas A Gupta, James Ackley, Jonathan L Kaufman, Lawrence H Boise

Blood Lymphat Cancer· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncolytic herpes simplex virus infects myeloma cells and .
Jayeeta Ghose, Ada Dona, Mariam Murtadha, Emine Gulsen Gunes, Enrico Caserta, Vikas A Gupta

Mol Ther Oncolytics· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Follow-Up Results of Lenalidomide, Bortezomib, and Dexamethasone Induction Therapy and Risk-Adapted Maintenance Approach in Newly Diagnosed Multiple Myeloma.
Nisha S Joseph, Jonathan L Kaufman, Madhav V Dhodapkar, Craig C Hofmeister, Dhwani K Almaula, Vikas A Gupta

J Clin Oncol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Electron transport chain activity is a predictor and target for venetoclax sensitivity in multiple myeloma.
Richa Bajpai, Aditi Sharma, Abhinav Achreja, Claudia L Edgar, Changyong Wei, Vikas A Gupta

Nat Commun· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis